AVGR
AVGR Real Time Price USDRecent trades of AVGR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AVGR's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Sep 30, 2016 Issue: Medicare/Medicaid
-
$10,000 Jul 15, 2016 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
AVGR Revenue by Segment or Geography
New patents grants
-
Patent Title: Occlusion-crossing devices, imaging, and atherectomy devices Mar. 25, 2025
-
Patent Title: Occlusion-crossing devices, atherectomy devices, and imaging Mar. 25, 2025
-
Patent Title: Optical coherence tomography for biological imaging Dec. 31, 2024
-
Patent Title: Atherectomy catheter drive assemblies Dec. 24, 2024
-
Patent Title: Occlusion-crossing devices Dec. 17, 2024
-
Patent Title: Atherectomy catheter with shaped distal tip Dec. 10, 2024
-
Patent Title: Occlusion-crossing devices Nov. 12, 2024
-
Patent Title: Methods of using atherectomy catheter with deflectable distal tip Sep. 17, 2024
-
Patent Title: Catheter-based off-axis optical coherence tomography imaging system Aug. 06, 2024
-
Patent Title: Guidewire positioning catheter Jun. 04, 2024
-
Patent Title: Tissue collection device for catheter May. 14, 2024
-
Patent Title: Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters May. 07, 2024
-
Patent Title: Atherectomy catheter with serrated cutter Apr. 16, 2024
-
Patent Title: Identification of elastic lamina to guide interventional therapy Apr. 02, 2024
-
Patent Title: High speed chronic total occlusion crossing devices Mar. 19, 2024
-
Patent Title: Occlusion-crossing devices, imaging, and atherectomy devices Feb. 20, 2024
-
Patent Title: Chronic total occlusion crossing devices with imaging Feb. 06, 2024
-
Patent Title: Optical coherence tomography for biological imaging Dec. 12, 2023
-
Patent Title: Occlusion-crossing devices Oct. 24, 2023
-
Patent Title: Optical pressure sensor assembly Aug. 15, 2023
-
Patent Title: Atherectomy catheter with laterally-displaceable tip Aug. 08, 2023
-
Patent Title: Optical coherence tomography with graded index fiber for biological imaging May. 16, 2023
-
Patent Title: Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters Apr. 18, 2023
-
Patent Title: Atherectomy catheters with imaging Aug. 09, 2022
-
Patent Title: Atherectomy catheter with serrated cutter Aug. 02, 2022
-
Patent Title: Atherectomy catheter Jul. 12, 2022
-
Patent Title: Catheter device with detachable distal end May. 31, 2022
-
Patent Title: Atherectomy catheters and occlusion crossing devices Mar. 29, 2022
-
Patent Title: Optical coherence tomography for biological imaging Mar. 29, 2022
-
Patent Title: Oct imaging catheter with lag correction Mar. 22, 2022
-
Patent Title: Atherectomy catheter with shapeable distal tip Jan. 18, 2022
-
Patent Title: Atherectomy catheter drive assemblies Dec. 28, 2021
-
Patent Title: High speed chronic total occlusion crossing devices Oct. 19, 2021
-
Patent Title: Occlusion-crossing devices, atherectomy devices, and imaging Oct. 05, 2021
-
Patent Title: Occlusion-crossing devices, imaging, and atherectomy devices Oct. 05, 2021
-
Patent Title: Tissue collection device for catheter Aug. 24, 2021
-
Patent Title: Guidewire positioning catheter Aug. 03, 2021
-
Patent Title: Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters Jun. 15, 2021
-
Patent Title: Occlusion-crossing devices Mar. 23, 2021
-
Patent Title: Optical coherence tomography with graded index fiber for biological imaging Mar. 23, 2021
-
Patent Title: Optical pressure sensor assembly Mar. 02, 2021
-
Patent Title: Catheter system and method for boring through blocked vascular passages Dec. 22, 2020
-
Patent Title: Identification of elastic lamina to guide interventional therapy Oct. 20, 2020
-
Patent Title: Catheter-based off-axis optical coherence tomography imaging system Aug. 04, 2020
-
Patent Title: Chronic total occlusion crossing devices with imaging Jul. 28, 2020
-
Patent Title: Atherectomy catheters devices having multi-channel bushings Feb. 25, 2020
-
Patent Title: Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters Feb. 25, 2020
-
Patent Title: Balloon atherectomy catheters with imaging Feb. 04, 2020
-
Patent Title: Atherectomy catheters and occlusion crossing devices Nov. 12, 2019
-
Patent Title: Atherectomy catheters and non-contact actuation mechanism for catheters Jul. 30, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to AVGR
Recent picks made for AVGR stock on CNBC
ETFs with the largest estimated holdings in AVGR
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AVGR stock a Buy, Sell, or Hold?
- What is the price target for $AVGR stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AVGR stock?
- Who owns the most shares of $AVGR stock?
- What funds own $AVGR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AVGR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.